Nightly Wearable Monitoring During Home-Based Submental Electrical Stimulation for Obstructive Sleep Apnea
Clinical Testing of a Physiological Signal Detection, Recognition and Feedback System for Obstructive Sleep Apnea: Home-Based Submental Transcutaneous Neuromuscular Electrical Stimulation With Nightly Ring-Type Monitoring
This single-arm pilot study evaluates the feasibility of nightly wearable monitoring with a ring-type sleep monitor during a 4-week home-based program of submental transcutaneous neuromuscular electrical stimulation in adults with obstructive sleep apnea, and describes changes in the ring-derived apnea-hypopnea index, sleep continuity, STOP-Bang score and upper-airway anatomy on CT before and after training.
Studie Overzicht
Toestand
Conditie
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
-
Kaohsiung City, Taiwan, 82445
- Werving
- E-Da Hospital
-
Contact:
- Chih-Chun Wang
- Telefoonnummer: +886-988-092-216
- E-mail: CCW5969@yahoo.com.tw
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Adults aged 20 to 65 years
- Obstructive sleep apnea diagnosed by a physician on polysomnography or an equivalent respiratory-event index test with AHI >= 5 events/h (mild 5-14.9, moderate 15-29.9, severe >= 30)
Exclusion Criteria:
- AHI < 5 events/h
- Pregnancy
- Prior nasal CPAP therapy
- Inflammation, rash, broken skin, swelling or infection at the stimulation site
- Cardiac disease, pacemaker or other implanted electronic or metallic device
- Allergic reaction to the device
- Concurrent use of other wearable medical devices (e.g., insulin pump)
- Cognitive impairment
- Suspected or confirmed epilepsy
- Central pain syndromes including headache
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: NVT
- Interventioneel model: Opdracht voor een enkele groep
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Submental NMES with nightly ring monitoring
Adults with obstructive sleep apnea perform home-based submental transcutaneous neuromuscular electrical stimulation (30 minutes every evening for 28 consecutive nights) and wear a ring-type sleep monitor every night during and after training. |
Submental transcutaneous neuromuscular electrical stimulation with the RS-18 wireless low-frequency stimulator (Jie-Mai Medical Technology; TFDA license 007859; off-label use). Biphasic symmetrical pulses, 250 us, 30-100 Hz program, intensity self-titrated to a strong but comfortable contraction. One 30-minute session every evening before bedtime for 28 consecutive nights at home, after supervised instruction. A ring-type wearable sleep monitor (Belun Ring BLS-100) worn on the finger every night during the 4-week training period to record pulse oximetry, heart rate and accelerometry signals for ring-derived apnea-hypopnea index, oxygen desaturation index and sleep parameters. Used for monitoring only; no therapeutic function. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Ring-Derived Apnea-Hypopnea Index (bAHI3)
Tijdsspanne: Baseline (first 7 nights) and end of training (nights 22-28 or last 7 recordings)
|
Change in the ring-derived apnea-hypopnea index (bAHI3, events/h) measured by a ring-type sleep monitor (Belun Ring BLS-100), comparing the mean of the first 7 nightly recordings with the mean of the last 7 nightly recordings. |
Baseline (first 7 nights) and end of training (nights 22-28 or last 7 recordings)
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Ring-Derived Apnea-Hypopnea Index Using the 4% Desaturation Criterion (bAHI4)
Tijdsspanne: Baseline (first 7 valid nights) and end of training (last 7 valid nights), 4 weeks
|
Ring-derived apnea-hypopnea index using the 4% oxygen desaturation criterion (bAHI4, events/h) measured by a ring-type sleep monitor (Belun Ring BLS-100), comparing the mean of the first 7 valid nightly recordings with the mean of the last 7 valid nightly recordings. |
Baseline (first 7 valid nights) and end of training (last 7 valid nights), 4 weeks
|
|
Change in Ring-Derived Sleep Efficiency
Tijdsspanne: Baseline (first 7 valid nights) and end of training (last 7 valid nights), 4 weeks
|
Ring-derived sleep efficiency (%, total sleep time divided by total recording time) measured by a ring-type sleep monitor (Belun Ring BLS-100), comparing the mean of the first 7 valid nightly recordings with the mean of the last 7 valid nightly recordings. |
Baseline (first 7 valid nights) and end of training (last 7 valid nights), 4 weeks
|
|
Change in STOP-Bang Score
Tijdsspanne: Baseline and end of 4-week training
|
STOP-Bang questionnaire score (range 0-8; higher scores indicate higher risk of obstructive sleep apnea), before vs after training. |
Baseline and end of 4-week training
|
|
Change in Minimal Nasopharyngeal Cross-Sectional Area on Supine CT
Tijdsspanne: Baseline and end of 4-week training
|
Minimal nasopharyngeal cross-sectional area (mm2) measured on supine computed tomography, before vs after training. |
Baseline and end of 4-week training
|
|
Post-Training Satisfaction Score
Tijdsspanne: End of 4-week training
|
Participant-rated satisfaction with the training program on a 0-100 scale (higher scores indicate greater satisfaction). |
End of 4-week training
|
|
Adherence: Proportion of Nights With a Valid Ring Recording
Tijdsspanne: 4 weeks
|
Number of nights with a valid ring-type monitor recording divided by the number of scheduled nights, expressed as a percentage. |
4 weeks
|
|
Number of Participants With Adverse Events
Tijdsspanne: During the 4-week training and up to 90 days of follow-up
|
Adverse events related to electrical stimulation or ring wear (e.g., skin irritation, pain, discomfort), recorded during training and follow-up. |
During the 4-week training and up to 90 days of follow-up
|
|
Change in Ring-Derived Oxygen Desaturation Index (ODI)
Tijdsspanne: Baseline (first 7 valid nights) and end of training (last 7 valid nights), 4 weeks
|
Ring-derived oxygen desaturation index (events/h) measured by a ring-type sleep monitor (Belun Ring BLS-100), comparing the mean of the first 7 valid nightly recordings with the mean of the last 7 valid nightly recordings. |
Baseline (first 7 valid nights) and end of training (last 7 valid nights), 4 weeks
|
|
Change in Ring-Derived Sleep-Onset Latency
Tijdsspanne: Baseline (first 7 valid nights) and end of training (last 7 valid nights), 4 weeks
|
Ring-derived sleep-onset latency (min) measured by a ring-type sleep monitor (Belun Ring BLS-100), comparing the mean of the first 7 valid nightly recordings with the mean of the last 7 valid nightly recordings. |
Baseline (first 7 valid nights) and end of training (last 7 valid nights), 4 weeks
|
|
Change in Ring-Derived Total Sleep Time
Tijdsspanne: Baseline (first 7 valid nights) and end of training (last 7 valid nights), 4 weeks
|
Ring-derived total sleep time (min) measured by a ring-type sleep monitor (Belun Ring BLS-100), comparing the mean of the first 7 valid nightly recordings with the mean of the last 7 valid nightly recordings. |
Baseline (first 7 valid nights) and end of training (last 7 valid nights), 4 weeks
|
Medewerkers en onderzoekers
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- AF10-008
- EMRP37113N (Andere identificatie: Institutional Review Board of E-Da Hospital)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
De-identified nightly data are available from the corresponding author on reasonable request.
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .